SEC Form 4 · accession 0001209191-15-023174
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hans Edgar Bishop
Officer — See Remarks · Director
Period of report
Mar 3, 2015
Accepted (ET)
Mar 5, 2015 · 7:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $48.06 | Mar 3, 2015 | A | 140,000 | A | — | Mar 2, 2025 | Common Stock | 140,000 | 140,000 | D |
Explanation of responses
- F11/48th of the shares subject to the option become vested and exercisable on April 3, 2015 and 1/48th of the shares subject to the option shall vest monthly thereafter.
Remarks
Chief Executive Officer and President